journals.plos.org /1 month ago

Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns base...

by Jing Qian, Rania Bassiouni, Yuxin Jin, Seeta Rajpara, Monica Neuman, Varun U. Khetan, Bodour Salhia, David W. Craig, Joseph W. Carlson, Lynda D. Roman, John D. Carpten High-gra...

Read source
journals.plos.org /1 month ago

Genome-Wide DNA methylation profiling of tissue-plasma pairs identifies Novel cfDNA biomarkers for the diagnosis of gast...

by Hailing Ou, Jinli Miao, Fusheng Ling, Jie Gao, Tingan Wang, Zhihua Ye, Chunbo Zhang, Mingwei Huang, Yuzhou Qin Screening for gastric cancer (GC) is critical for improving patie...

Read source
bioengineer.org /3 weeks ago

ORC1 Protein Rises with HBV Liver Disease Progression and Flags Poorer Survival

A study of 178 patients found that ORC1 expression rises from chronic hepatitis B to cirrhosis to HBV-associated liver cancer and that high expression is associated with poorer sur...

Read source
bioengineer.org /1 week ago

CLDN6 Promotes Colorectal Cancer Liver Metastasis via Distinct Signaling and Epigenetic Reprogramming

Researchers identified the surface marker CLDN6 as a driver of liver metastasis in aggressive consensus molecular subtype 4 colorectal cancer across multi-omics datasets and precli...

Read source
journals.plos.org /1 month ago

Integrated multi-omics analysis reveals the molecular landscape and therapeutic strategies in Chinese cervical cancer pa...

by Tao Pan, Xucui Zhuang, Ya Zhang, Jiyu Guo, Si Li, Can Zhang, Lili Han, Fuxia Li, Yueying Gao, Jinyang Yu, Yongsheng Li, Chaoyang Sun Genomic or transcriptomic sequencing guides...

Read source
bioengineer.org /3 weeks ago

TCGA study links coagulation-associated lncRNAs to prostate cancer prognosis

A TCGA-based prostate cancer study developed a coagulation-associated lncRNA prognostic signature, found distinct immune-related features in high-risk patients, and showed that sil...

Read source
bioengineer.org /5 days ago

Hypoxia-Driven SPP1 Macrophages Promote Fibrosis and Chemoembolization Resistance in Liver Cancer

Spatial multi-omic profiling reveals that transarterial chemoembolization promotes hypoxia-driven SPP1-positive macrophages that produce fibronectin, build immunosuppressive fibrot...

Read source
bioengineer.org /1 week ago

FADS1 Identified as Candidate Biomarker for MASH and Early-Onset Colorectal Cancer

Researchers have identified FADS1 as a candidate shared biomarker linking metabolic dysfunction-associated steatohepatitis to early-onset colorectal cancer through machine learning...

Read source
journals.plos.org /2 weeks ago

Transcriptome- and methylome-wide association studies prioritized lung cancer genes in East Asian populations

by Xingjie Hao, Minghan Qu, Yi Jiang, Cheng Wang, Ziwei Zhu, Pinpin Long, Chaolong Wang, Hongxia Ma, Shanshan Cheng The relationship between gene expression, DNA methylation, and...

Read source
qchron.com /4 weeks ago

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ES...

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR 0.69; 95% CI 0.54–0.89;...

Read source
bioengineer.org /1 week ago

Four Mitochondrial Metabolic Genes Predict Survival Outcomes in Colorectal Cancer

Researchers identified and experimentally validated four downregulated mitochondrial energy metabolism genes that predict overall survival outcomes in colorectal cancer.

Read source
qchron.com /3 weeks ago

Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvaluma...

HONG KONG, Oct. 25, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, multicenter, registr...

Read source
healio.com /1 month ago

‘Key’ differences in colorectal cancer with liver metastases

Early-onset colorectal cancer with liver-only metastases can have significant differences in biology from late-onset malignancies.A study of nearly 1,700 individuals from Australia...

Read source
bioengineer.org /3 days ago

Colorectal Carcinoma Biopsies Show Ubiquitous PD-L1 and Bcl-2 Protein Expression

A hospital-based evaluation of sixty male colorectal carcinoma patients in Anbar Governorate detected widespread immunohistochemical expression of both PD-L1 and Bcl-2 proteins acr...

Read source
qchron.com /4 weeks ago

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentati...

PFS was significantly prolonged: as assessed by BICR, the risk of disease progression or death was reduced by 51% (HR 0.49; 95% CI 0.36-0.65; P

Read source
medinform.jmir.org /1 month ago

Development of an Interpretable Triage Tool for Colorectal Polyp Risk Stratification Within a Population-Based Screening...

Background: Colorectal polyps are a major source of precancerous lesions in colorectal cancer (CRC). In many population-based screening programs, a major challenge is the efficient...

Read source
prweb.com /1 week ago

CIMA Sciences Highlights OWLiver Findings in Landmark Lancet LITMUS Study on Noninvasive MASLD Testing

Multinational, biopsy-validated study identifies encouraging OWLiver screening findings for at-risk MASH, reinforcing the importance of identifying fatty liver disease beyond advan...

Read source
healio.com /1 month ago

Liver transplant for colorectal liver metastases ‘promising’

NASHVILLE, Tenn. — Liver transplantation yielded favorable short- and intermediate-term outcomes for patients with unresectable colorectal liver metastases confined to the liver, a...

Read source
genengnews.com /4 weeks ago

Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities

Researchers analyzed mulitomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinatio...

Read source
bioengineer.org /1 month ago

Gut Metabolite Genes Could Predict Colorectal Cancer Survival and Immunotherapy Response

Researchers built a four-gene signature based on propionate metabolism that stratifies colorectal cancer patients by survival risk and links tumor metabolism to immune features and...

Read source
qchron.com /2 weeks ago

Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer

HONG KONG, Nov. 4, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanc...

Read source
bioengineer.org /1 week ago

KLHL6 protein drives colorectal cancer liver spread via MBD2 degradation

A study in the Journal of Experimental & Clinical Cancer Research identifies KLHL6 as a driver of colorectal cancer liver metastasis through the degradation of MBD2 and activat...

Read source
healio.com /1 month ago

Updated blood-based CRC test improves APL sensitivity

NASHVILLE, Tenn. — An updated version of the blood-based SimpleScreen CRC screening test improved detection of advanced precancerous lesions while maintaining high sensitivity for...

Read source
bioengineer.org /3 weeks ago

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 stabilizes the glutamine transporter ASCT2 by blocking SPOP-driven ubiquitin-proteasome degradation, sustaining AKT/mTORC1 signaling in hepatocellular carcinoma cells.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.